18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer
- PMID: 23084013
- DOI: 10.1016/j.remn.2011.12.001
18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer
Abstract
Aim: To analyse the correlation between (18)F-FDG uptake assessed by PET/CT in locally advanced breast tumours and histopathological and immunohistochemical prognostic factors.
Material and methods: Thirty-six women with breast cancer were prospectively evaluated. PET/CT was requested in the initial staging previous to adjuvant chemotherapy (multicentric study). All the patients underwent an (18)F-FDG PET/CT with a dual-time-point acquisition. Both examinations were evaluated qualitatively and semiquantitatively with calculation of SUVmax values in PET-1 (SUV-1) and in PET-2 (SUV-2) and the percentage variation of the standard uptake values (retention index) between PET-1 and PET-2. Clinical and metabolic stages were assessed according to TNM classification. The biological prognostic parameters, such as the steroid receptor status, p53 and c-erbB-2 expression, proliferation rate (Ki-67), and grading were determined from tissue of the primary tumour. Metabolic and biological parameters were correlated.
Results: A positive relationship was found between semiquantitative metabolic parameters and biological parameters. SUV-1 and SUV-2 values did not show significant statistical correlation (p<.05) except for the clinical tumour size. About the biological parameters, retention index showed the best results with positive and significant relation (p<.05) with estrogen and progesterone receptor status and Ki-67. Isolated SUV values did not show significant relation to these parameters.
Conclusion: Retention index showed the best relation with biological parameters compared to isolated SUVmax values. These data suggest that SUV change over time is a prognostic marker.
Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved.
Similar articles
-
18F-FDG retention index and biologic prognostic parameters in breast cancer.Clin Nucl Med. 2012 May;37(5):460-6. doi: 10.1097/RLU.0b013e31823926c9. Clin Nucl Med. 2012. PMID: 22475895 Clinical Trial.
-
Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):72-9. doi: 10.1007/s00259-012-2244-3. Epub 2012 Sep 28. Eur J Nucl Med Mol Imaging. 2013. PMID: 23053321 Clinical Trial.
-
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.World J Surg Oncol. 2015 Mar 15;13:113. doi: 10.1186/s12957-015-0522-9. World J Surg Oncol. 2015. PMID: 25889560 Free PMC article.
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
-
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.Q J Nucl Med Mol Imaging. 2015 Mar;59(1):4-17. Epub 2015 Feb 19. Q J Nucl Med Mol Imaging. 2015. PMID: 25693420 Review.
Cited by
-
Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.Tumour Biol. 2014 Nov;35(11):11613-20. doi: 10.1007/s13277-014-2495-7. Epub 2014 Aug 20. Tumour Biol. 2014. PMID: 25139100
-
Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1309-18. doi: 10.1007/s00259-013-2657-7. Epub 2014 Apr 18. Eur J Nucl Med Mol Imaging. 2014. PMID: 24744045 Clinical Trial.
-
Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):831-837. doi: 10.1007/s00259-019-4259-5. Epub 2019 Jan 16. Eur J Nucl Med Mol Imaging. 2019. PMID: 30648199
-
Dual-Time 18F-FDG PET/CT Imaging in Initial Locoregional Staging of Breast Carcinoma: Comparison with Conventional Imaging and Pathological Prognostic Factors.Indian J Surg. 2016 Oct;78(5):382-389. doi: 10.1007/s12262-016-1486-x. Epub 2016 Apr 23. Indian J Surg. 2016. PMID: 27994334 Free PMC article.
-
[Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(5):473-480. doi: 10.3785/j.issn.1008-9292.2017.10.04. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 29488712 Free PMC article. Chinese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous